Privia Health Group Inc. Common Stock (PRVA)

About PRVA

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that…

Sector

Health Care

Industry

Medical/Nursing Services

Employees

1,226

Website

www.priviahealth.com/

Fundamentals

1-day range

$20.71$21.25

Market cap

$3.00B

P/E (trailing)

98.83

P/E (forward)

19.55

EPS (trailing)

$0.22

Dividend yield

—

Beta

0.80

Avg. volume

1.19M

Forecasts

18 analyst ratings

Privia Health Group Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• PRVA

  Privia Health Group Inc. Common Stock

  $20.79

  ▼ 0.36%
  Market cap $3.00BP/E 98.83
  $19.53$28.82
• ADUS

  Addus HomeCare Corporation Common Stock

  $115.5

  ▼ 2.13%
  Market cap $2.18BP/E 21.10
  $87.95$124.44
• PNTG

  The Pennant Group Inc. Common Stock

  $37.14

  ▼ 1.81%
  Market cap $1.40BP/E 42.00
  $22.26$42.69
• TDOC

  Teladoc Health Inc. Common Stock

  $6.5

  ▲ 2.12%
  Market cap $1.21BP/E —
  $4.4$9.89
• AUNA

  Auna SA Class A Ordinary Shares

  $5.17

  ▲ 1.17%
  Market cap $388.57MP/E 19.21
  $4.09$6.85
• AIRS

  AirSculpt Technologies Inc. Common Stock

  $2.59

  ▼ 0.77%
  Market cap $344.26MP/E —
  $1.51$12
• LFMD

  LifeMD Inc. Common Stock

  $3.14

  ▼ 3.68%
  Market cap $180.39MP/E 829.68
  $2.56$7.32

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Privia Health Group, Inc. 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/7/2026
• Privia Health Group (NASDAQ:PRVA) Jumps on Q2 Revenue Beat
  ChartMill · 8/6/2026
• Privia Health Group, Inc. (PRVA) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/6/2026
• CORRECTION: Privia Health Gr Q2 Adj. EPS $0.19 Beats $0.07 Estimate, Sales $632.600M Beat $599.186M Estimate
  Benzinga · 8/6/2026
• Privia Health Gr Affirms FY2026 Sales Guidance of $2.350B-$2.450B vs $2.422B Est
  Benzinga · 8/6/2026

• David Mountcastle · July 9, 2026 · Sale

  21.3K @ $27.67
• David Mountcastle · July 7, 2026 · Sale

  600 @ $27.57
• Matthew Shawn Morris · July 6, 2026 · Option Exercise

  53.7K @ $2
• Matthew Shawn Morris · July 6, 2026 · Sale

  53.7K @ $27.24
• David Mountcastle · July 2, 2026 · Sale

  24.7K @ $27.5
• Matthew Shawn Morris · July 2, 2026 · Option Exercise

  59.0K @ $2
• Matthew Shawn Morris · July 2, 2026 · Sale

  59.0K @ $27.33
• Matthew Shawn Morris · July 1, 2026 · Option Exercise

  82.7K @ $2
• Matthew Shawn Morris · July 1, 2026 · Sale

  37.0K @ $26.93
• Matthew Shawn Morris · July 1, 2026 · Sale

  45.6K @ $26.52
• Matthew Shawn Morris · June 30, 2026 · Option Exercise

  52.8K @ $2
• Matthew Shawn Morris · June 30, 2026 · Sale

  52.8K @ $25.72
• Jaewon Ryu · May 20, 2026 · Grant

  8.5K
• Pamela O. Kimmet · May 20, 2026 · Grant

  8.5K
• Thomas A. McCarthy · May 20, 2026 · Grant

  8.5K

Institutional Ownership

March 31, 2026

Total shares held

113.41M

Total value held

$2.22B

Institutional holders

282